IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $564,292 | -79.1% | 53,035 | -79.3% | 0.05% | -71.5% |
| Q1 2023 | $2,700,000 | +9.4% | 256,654 | +28.9% | 0.16% | +1.9% |
| Q4 2022 | $2,467,345 | +32.3% | 199,140 | +10.6% | 0.16% | +32.8% |
| Q3 2022 | $1,865,000 | +44.5% | 179,975 | +60.7% | 0.12% | +79.4% |
| Q2 2022 | $1,291,000 | +38.8% | 111,999 | +57.3% | 0.07% | +30.8% |
| Q3 2021 | $930,000 | -22.0% | 71,214 | -23.1% | 0.05% | -18.8% |
| Q2 2021 | $1,192,000 | +35.9% | 92,642 | +18.1% | 0.06% | +28.0% |
| Q1 2021 | $877,000 | -15.1% | 78,453 | -13.5% | 0.05% | -33.3% |
| Q4 2020 | $1,033,000 | -59.7% | 90,657 | -68.2% | 0.08% | -9.6% |
| Q3 2020 | $2,566,000 | -18.6% | 285,308 | -6.6% | 0.08% | +2.5% |
| Q2 2020 | $3,154,000 | +907.7% | 305,593 | +885.2% | 0.08% | +912.5% |
| Q1 2020 | $313,000 | – | 31,017 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |